ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
10.52
-0.74 (-6.57%)
Nov 20, 2026, 4:00 PM EST - Market closed
ArriVent BioPharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Maintains $30 → $28 | Buy | Maintains | $30 → $28 | +166.16% | Nov 16, 2026 |
| Citi | Citi | Buy Maintains $20 → $23 | Buy | Maintains | $20 → $23 | +118.63% | Nov 10, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $21 → $24 | Buy | Maintains | $21 → $24 | +128.14% | Nov 10, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $22 | Buy | Maintains | $22 | +109.13% | Nov 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $25 | Buy | Maintains | $25 | +137.64% | Nov 10, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $27 | Buy | Reiterates | $27 | +156.65% | Nov 10, 2026 |
| BTIG | BTIG | Buy Maintains $29 | Buy | Maintains | $29 | +175.67% | Nov 10, 2026 |
| Clear Street | Clear Street | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 25, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.